IRVINE, Calif.--(BUSINESS WIRE)--Alsius Corporation (Nasdaq:ALUS), the worldwide leader in intravascular temperature management products, today pre-released preliminary unaudited financial results for its third quarter ended September 30, 2007, indicating that revenues will be below expectations. Revenue for the third quarter was $1.9 million, compared with $1.8 million in the third quarter of 2006. The revenue shortfall was greater in Europe than in the U.S., where the company had its strongest quarterly revenue in history. Alsius also said that its forecast of year-end revenues of $11.5 - $12.5 million will probably not be achieved, and is now estimated to be in the $8.5 – 9.5 million range.
